Hsbc Holdings PLC Ptc Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 20,967 shares of PTCT stock, worth $921,289. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,967
Previous 18,918 10.83%
Holding current value
$921,289
Previous $578,000 34.43%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $62,269 - $77,165
2,049 Added 10.83%
20,967 $777,000
Q2 2024

Aug 12, 2024
SELL
$24.69 - $40.12 $105,697 - $171,753
-4,281 Reduced 18.45%
18,918 $578,000
Q1 2024

May 15, 2024
BUY
$24.15 - $31.95 $142,798 - $188,920
5,913 Added 34.21%
23,199 $674,000
Q4 2023

Feb 12, 2024
SELL
$18.07 - $29.37 $236,102 - $383,748
-13,066 Reduced 43.05%
17,286 $476,000
Q3 2023

Nov 13, 2023
SELL
$22.41 - $41.99 $195,303 - $365,942
-8,715 Reduced 22.31%
30,352 $680,000
Q2 2023

Aug 11, 2023
BUY
$40.4 - $59.1 $1.02 Million - $1.49 Million
25,241 Added 182.56%
39,067 $1.59 Million
Q1 2023

May 15, 2023
SELL
$38.16 - $48.86 $1.21 Million - $1.55 Million
-31,740 Reduced 69.66%
13,826 $669,000
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $999,462 - $1.63 Million
29,808 Added 189.16%
45,566 $1.74 Million
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $351,079 - $451,747
-8,389 Reduced 34.74%
15,758 $803,000
Q2 2022

Aug 11, 2022
SELL
$25.6 - $45.23 $966,195 - $1.71 Million
-37,742 Reduced 60.98%
24,147 $969,000
Q1 2022

May 16, 2022
SELL
$33.33 - $44.6 $295,803 - $395,825
-8,875 Reduced 12.54%
61,889 $2.31 Million
Q4 2021

Feb 11, 2022
BUY
$35.36 - $41.86 $52,686 - $62,371
1,490 Added 2.15%
70,764 $2.82 Million
Q3 2021

Nov 12, 2021
BUY
$37.01 - $44.74 $1.55 Million - $1.88 Million
41,941 Added 153.44%
69,274 $2.59 Million
Q2 2021

Aug 13, 2021
BUY
$37.95 - $49.37 $352,935 - $459,141
9,300 Added 51.57%
27,333 $1.16 Million
Q1 2021

May 14, 2021
BUY
$46.8 - $68.92 $513,068 - $755,569
10,963 Added 155.06%
18,033 $853,000
Q4 2020

Feb 12, 2021
SELL
$47.96 - $67.64 $832,393 - $1.17 Million
-17,356 Reduced 71.06%
7,070 $431,000
Q3 2020

Nov 12, 2020
BUY
$45.41 - $57.07 $1.11 Million - $1.39 Million
24,426 New
24,426 $1.16 Million
Q2 2020

Aug 14, 2020
SELL
$42.56 - $54.98 $212,757 - $274,845
-4,999 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$32.37 - $59.36 $5,373 - $9,853
166 Added 3.43%
4,999 $221,000
Q4 2019

Feb 14, 2020
BUY
$32.22 - $50.07 $155,719 - $241,988
4,833 New
4,833 $232,000
Q3 2018

Nov 13, 2018
SELL
$33.9 - $47.77 $438,021 - $617,236
-12,921 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$25.7 - $47.88 $332,069 - $618,657
12,921 New
12,921 $436,000

Others Institutions Holding PTCT

# of Institutions
220
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.14B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email